HCV NS3/4A Protease Inhibitors [MoA] - N0000182638

Pharmacologic Class Information

Pharmacologic Code N0000182638
Pharmacologic Name HCV NS3/4A Protease Inhibitors
Pharmacologic Uses
  • hepatitis C virus (HCV) NS3/4A protease inhibitor
Pharmacologic Concept Mechanisms of Action - [MoA]
Pharmacologic Concept Description This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept.

NDC Products with HCV NS3/4A Protease Inhibitors

The table contains 4 products whose active ingredient are classified under the same pharmacologic class HCV NS3/4A Protease Inhibitors [MoA].

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
0006-3074Zepatier Non-Proprietary Name: Elbasvir And GrazoprevirTablet, Film CoatedOralMerck Sharp & Dohme LlcACTIVE
0074-2600Mavyret Non-Proprietary Name: Glecaprevir And PibrentasvirPelletOralAbbvie Inc.ACTIVE
0074-2625Mavyret Non-Proprietary Name: Glecaprevir And PibrentasvirTablet, Film CoatedOralAbbvie Inc.ACTIVE
61958-2401Vosevi Non-Proprietary Name: Sofosbuvir, Velpatasvir, And VoxilaprevirTablet, Film CoatedOralGilead Sciences, Inc.ACTIVE